Abstract:Despite the progress of cardiovascular medicine, ischemia-reperfusion injury can contribute to increased mortality and prolonged hospitalization after myocardial infarction. Ischemia-reperfusion injury pathophysiology encompasses many cells including cardiomyocytes, fibroblasts, mesenchymal stromal cells, vascular endothelial and smooth muscle cells, platelets, polymorphonuclear cells, macrophages, and T lymphocytes. However, specific mechanisms for all contributing cells and molecular pathways are still under investigation. What is definitely known is that endothelial dysfunction, immunity activation and inflammatory response are crucial events during ischemia-reperfusion injury while toll-like receptors, inflammasomes, reactive oxygen species, intracellular calcium overload and mitochondrial permeability transition pore opening consist of key molecular mediators. Indicatively, cardiac fibroblasts through inflammasome activation mediate the initial inflammatory response. Cardiac mesenchymal stromal cells can respond to myocardial injury by pro-inflammatory activation. Endothelial cell activation contributes to the impaired vasomotion, inflammation and thrombotic events and together with platelet activation leads to microcirculation dysfunction and polymorphonuclear cells recruitment promoting inflammation. Polymorphonuclear cells and monocytes/macrophages subsets are critically involved in the inflammation process by producing toxic proteolytic enzymes and reactive oxygen species. T cells subsets are also involved in several stages of ischemia-reperfusion injury. In this review, we summarize the specific contribution of each of the above cells and the related molecular pathways in the pathophysiology of ischemia-reperfusion injury.

[Ischemia-Reperfusion Injury: Molecular Mechanisms of Pathogenesis and Methods of Their Correction]

Pathogenetic scenarios of the development of brain ischemia and the main elements of the ischemic cascade

Molecular pathophysiological mechanisms of ischemia/reperfusion injuries after recanalization therapy for acute ischemic stroke.

Reperfusion injury: a review of the pathophysiology, clinical manifestations and therapeutic options

The Mechanisms and Strategies to Protect from Hepatic Ischemia-Reperfusion Injury.

Myocardial ischemia/reperfusion injury: Mechanisms of injury and implications for management (Review)

Cellular and Molecular Mechanisms of Endothelial Ischemia/reperfusion Injury: Perspectives and Implications for Postischemic Myocardial Protection.

Cerebral Ischemia and Reperfusion: The Pathophysiologic Concept as a Basis for Clinical Therapy

Cellular and molecular mechanisms of hepatic ischemia-reperfusion injury: The role of oxidative stress and therapeutic approaches

Cell Death Mechanisms in Cerebral Ischemia–Reperfusion Injury

Cellular mechanisms and pathways in myocardial reperfusion injury

Ischemia/Reperfusion Injury Revisited: An Overview of the Latest Pharmacological Strategies

Advances in Defense Mechanism of Hepatic Ischemia-reperfusion Injury

Neuroinflammation in Cerebral Ischemia and Ischemia/Reperfusion Injuries: From Pathophysiology to Therapeutic Strategies

Pathophysiological Mechanism of Ischemia/Reperfusion Injury

Myocardial Ischemia-Reperfusion Injury: Unraveling Pathophysiology, Clinical Manifestations, and Emerging Prevention Strategies

Molecular Mechanisms of Ischemia–Reperfusion Injury in Brain: Pivotal Role of the Mitochondrial Membrane Potential in Reactive Oxygen Species Generation

Therapeutic Targets for Regulating Oxidative Damage Induced by Ischemia-Reperfusion Injury: A Study from a Pharmacological Perspective

Free Radical Damage in Ischemia-Reperfusion Injury: An Obstacle in Acute Ischemic Stroke after Revascularization Therapy

Clinical manifestations and basic mechanisms of myocardial ischemia/reperfusion injury